论文部分内容阅读
ESPAC-4:A multicenter,international,open-label randomized controlled phase Ⅲ trial ofadjuvant combin
【作 者】
:
【机 构】
:
University of Liverpool,Liverpool,United Kingdom
【出 处】
:
2016年临床肿瘤学新进展学术研讨会
【发表日期】
:
2016年5期
其他文献
FOLFIRINOX combined to targeted therapy according RAS status for colorectal cancer patients with liv
会议
Efficacy of palbociclib plus fulvestrant(P+F)in patients(pts)with metastatic breast cancer(MBC)and E
会议
CREST:Randomised phase Ⅲ study of stenting as a bridge to surgery in obstructingcolorectal cancer-Re
会议
The potential of circulating tumor DNA(ctDNA)to reshape the design of clinical trialstesting adjuvan
会议
NCI9673:A multi-institutional eETCTN phase Ⅱ study of nivolumab in refractory metastatic squamous ce
会议
FAST:An international,multicenter,randomized,phase Ⅱ trial of epirubicin,oxaliplatin,and capecitabin
会议
NETTER-1 phase Ⅲ:Efficacy and safety results in patients with midgut neuroendocrine tumors treated w
会议
Phase Ⅲ randomized study of sorafenib plus doxorubicin versus sorafenib in patients with advanced he
会议